Notably, in TLSs, a substantial proportion (18%, median value) of EBNA2+ cells co-expresses the proliferation marker Ki67 (Figure 1G,H), suggesting the presence of newly infected proliferating B cell blasts in the latency III/growth phase of EBV infection. The gene discussed is MKI67; the disease is Epstein-Barr virus infection.